127 related articles for article (PubMed ID: 33393317)
1. Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction.
Nemcekova V; Malikova E; Goncalvesova E; Krenek P; Klimas J
Bratisl Lek Listy; 2021; 122(1):28-33. PubMed ID: 33393317
[TBL] [Abstract][Full Text] [Related]
2. Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.
Lyle MA; Iyer SR; Redfield MM; Reddy YNV; Felker GM; Cappola TP; Hernandez AF; Scott CG; Burnett JC; Pereira NL
JACC Heart Fail; 2020 Jan; 8(1):70-80. PubMed ID: 31392960
[TBL] [Abstract][Full Text] [Related]
3. Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
Yoshihisa A; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Takeishi Y
ESC Heart Fail; 2019 Apr; 6(2):291-296. PubMed ID: 30681298
[TBL] [Abstract][Full Text] [Related]
4. Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
Lupón J; Santiago-Vacas E; Cediel G; Codina P; Domingo M; Revuelta-López E; Zamora E; Spitaleri G; Santesmases J; Núñez J; Bayes-Genis A
PLoS One; 2021; 16(5):e0249674. PubMed ID: 33989294
[TBL] [Abstract][Full Text] [Related]
5. Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study.
Choi IJ; Lim S; Hwang Y; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
BMC Cardiovasc Disord; 2020 Aug; 20(1):360. PubMed ID: 32762650
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure: A Pilot Study.
Bayés-Genís A; Barallat J; Pascual-Figal D; Nuñez J; Miñana G; Sánchez-Mas J; Galan A; Sanchis J; Zamora E; Pérez-Martínez MT; Lupón J
JACC Heart Fail; 2015 Aug; 3(8):641-4. PubMed ID: 26251092
[TBL] [Abstract][Full Text] [Related]
7. Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF.
Prausmüller S; Arfsten H; Spinka G; Freitag C; Bartko PE; Goliasch G; Strunk G; Pavo N; Hülsmann M
J Am Heart Assoc; 2020 Jun; 9(11):e015071. PubMed ID: 32427034
[TBL] [Abstract][Full Text] [Related]
8. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
[TBL] [Abstract][Full Text] [Related]
9. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
Pan W; Yang D; Yu P; Yu H
BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
[TBL] [Abstract][Full Text] [Related]
10. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
11. Soluble Neprilysin - Cardiac Function and Outcome in Hypertrophic Cardiomyopathy.
Yoshihisa A; Yokokawa T; Ichijo Y; Kimishima Y; Kanno Y; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Takeishi Y
Circ Rep; 2019 May; 1(6):261-267. PubMed ID: 33693148
[No Abstract] [Full Text] [Related]
12. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
13. Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction.
Goliasch G; Pavo N; Zotter-Tufaro C; Kammerlander A; Duca F; Mascherbauer J; Bonderman D
Eur J Heart Fail; 2016 Jan; 18(1):89-93. PubMed ID: 26725876
[TBL] [Abstract][Full Text] [Related]
14. The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations.
Núñez J; Núñez E; Revuelta-López E; Miñana G; Barallat J; Bodi V; Sanchis J; Aimo A; Emdin M; Lupón J; Husser O; Bayes-Genis A
Sci Rep; 2021 Mar; 11(1):5940. PubMed ID: 33723360
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
[TBL] [Abstract][Full Text] [Related]
16. The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.
Arrigo M; Vodovar N; Nougué H; Sadoune M; Pemberton CJ; Ballan P; Ludes PO; Gendron N; Carpentier A; Cholley B; Bizouarn P; Cohen-Solal A; Singh JP; Szymonifka J; Latremouille C; Samuel JL; Launay JM; Pottecher J; Richards AM; Truong QA; Smadja DM; Mebazaa A
Eur Heart J; 2018 May; 39(20):1794-1798. PubMed ID: 29244074
[TBL] [Abstract][Full Text] [Related]
17. Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure.
Núñez J; Núñez E; Barallat J; Bodí V; Miñana G; Pastor MC; Sanchis J; Lupón J; Bayes-Genis A
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862951
[TBL] [Abstract][Full Text] [Related]
18. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
[TBL] [Abstract][Full Text] [Related]
19. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
